Intellia Therapeutics Inc
(NAS:NTLA)
$
11.94
+0.69 (+6.13%)
Market Cap: 1.67 Bil
Enterprise Value: 1.37 Bil
PE Ratio: 0
PB Ratio: 2.31
GF Score: 70/100 
Intellia Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
May 12, 2026 / 10:40PM GMT
Release Date Price:
$13.99
(-2.98%)
Alec Stranahan
Bofa Merrill Lynch Asset Holdings Inc - Analyst
Let's get going. Thanks for joining this session with Intellia Therapeutics. My name is Alec Stranahan. I cover SMid biotech here at Bank of America. And I'm pleased to be joined by Ed Dulac, Chief Financial Officer of Intellia. Thanks for being here, Ed.
Edward Dulac
Intellia Therapeutics Inc - Chief Financial Officer, Executive Vice President, Treasurer and Principal Financial Officer
Thanks for having us. Great conference again. So yeah, really productive day. Look forward to the discussion.
Alec Stranahan;Edward Dulac
Bofa Merrill Lynch Asset Holdings Inc - Analyst;Intellia Therapeutics Inc - Chief Financial Officer, Executive Vice President, Treasurer and Principal Financial
Great. Yeah, another year in Vegas. Maybe just to start, you've had some recent updates. Maybe if you just want to kind of level set and step through the most important ones, whether that's lonvo-z or the next few studies we're starting.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers